Pictet Asset Management
KRTX

Pictet Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Pictet Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,740
Closed -$1.18M – 2038
2023
Q4 		$1.18M Sell
3,740
-223,045
-98% -$43.4M ﹤0.01% 956
2023
Q3 		$38.3M Buy
+226,785
New +$42.6M 0.05% 330

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Pictet Asset Management's KRTX Position: Q1 2024 in Review

Pictet Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 3,740 shares — an estimated $1.18M sold.

Pictet Asset Management first reported a position in KRTX in Q3 2023 and held it in 2 quarters. The position peaked at $38.3M in Q3 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Pictet Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Pictet Asset Management sold 3,740 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.18M.
  • Pictet Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Pictet Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $38.3M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Pictet Asset Management's 13F filing for Q1 2024, filed 14 May 2024.